Table of Contents Table of Contents
Previous Page  1558 / 2894 Next Page
Information
Show Menu
Previous Page 1558 / 2894 Next Page
Page Background

1. Goodnough LT, Shander A, Spence RK: Bloodless

medicine: Clinical care without allogeneic blood

transfusion. Transfusion 43:668, 2003.

2. NHLBI Expert Panel: Transfusion alert: Use of

autologous blood. Transfusion 35703, 1995.

3. Goodnough LT, Brecher ME, Kanter MH, et al:

Medical progress: Transfusion medicine. Part II.

Blood conservation. N Engl J Med 340:525, 1999.

4. Goodnough LT, Shander A, Brecher ME: Transfu-

sion medicine: Looking toward the future. Lancet

361:161, 2003.

5. Goodnough LT, Brecher ME, Kanter MH, et al:

Medical progress: Transfusion medicine. Part I.

Blood transfusion. N Engl J Med 340:439, 1999.

6. Brecher ME, Goodnough LT: The rise and fall in

preoperative autologous blood donation. Transfu-

sion 42:1618, 2002.

7. Finucane ML, Slovic P, Mertz CK: Public perception

of the risk of blood transfusion. Transfusion

40:1017, 2002.

8. American Association of Blood Banks: Standards

for Blood Banks and Transfusion Services, 21st ed.

Bethesda, MD, American Association of Blood

Banks, 2002.

9. Mintz PD: Participation of HIV-infected patients in

autologous blood programs. JAMA 269:2892, 1993.

10. Mintz PD, Nordine RB, Henry JB, et al: Expected

hemotherapy in elective surgery. NY State J Med

76:532, 1976.

11. Goodnough LT: Preoperative autologous donation.

In Spence RK (ed): Problems in General Surgery.

Philadelphia, Lippincott Williams & Wilkins, 2000,

pp 25–31.

12. Bierbaum BE, Callaghan JJ, Galante JO, et al: An

analysis of blood management in patients having

total hip or knee arthroplasty. J Bone Joint Surg Am

81:2, 1999.

13. Renner SW, Howanitz PJ, Bachner P: Preoperative

autologous blood donation in 612 hospitals. Arch

Pathol Lab Med 116:613, 1992.

14. Silvergleid AJ: Safety and effectiveness of predeposit

autologous transfusions in preteen and adolescent

children. JAMA 257:3403, 1987.

15. Mann M, Sacks HJ, Goldfinger D: Safety of autolo-

gous blood donation prior to elective surgery for a

variety of potentially high risk patients. Transfusion

23:229, 1983.

16. Popovsky MA, Whitaker B, Arnold NL: Severe

outcomes of allogeneic and autologous blood dona-

tion: Frequency and characterization. Transfusion

35:734, 1995.

17. Thomas MJG, Gillon J, Desmond MJ: Preoperative

autologous blood donation. Transfusion 36:633, 1996.

18. Sayers MH: Controversies in transfusion medicine:

Autologous blood donation in pregnancy: Con

Transfusion 30:172, 1990.

19. Larocque BJ, Gilbert K, Brien WF: Prospective

validation of a point score system for predicting

blood transfusion following hip or knee replace-

ment. Transfusion 38:932, 1998.

20. Brecher MA, Monk TG, Goodnough LT: A standar-

dized method for calculating blood loss. Transfu-

sion 37:1070, 1997.

21. Goodnough LT, Skikne B, Brugnara C: Erythropoie-

tin, iron, and erythropoiesis. Blood 96:823, 2000.

22. Cohen JA, Brecher ME: Preoperative autologous

blood donation: Benefit or detriment? A mathema-

tical analysis. Transfusion 35:640, 1995.

23. Kanter MH, Van Maanen D, Anders KH, et al:

Preoperative autologous blood donation before

elective hysterectomy. JAMA 276:798, 1996.

24. Goodnough LT, Rudnick S, Price TH, et al: Increa-

sed preoperative collection of autologous blood

with recombinant human erythropoietin therapy. N

Engl J Med 321:1163, 1989.

25. Goodnough LT, Price TH, Rudnick S, et al: Preope-

rative red blood cell production in patients under-

going aggressive autologous blood phlebotomy with

and without erythropoietin therapy. Transfusion

32:441, 1992.

26. Goodnough LT, Price TH, Friedman KD, et al: A

phase III trial of recombinant human erythropoie-

tin therapy in non-anemic orthopedic patients

subjected to aggressive autologous blood phlebo-

tomy: Dose, response, toxicity, efficacy. Transfusion

34:66, 1994.

27. Goodnough LT, Monk TG, Andriole GL: Erythro-

poietin therapy. N Engl J Med 336:933, 1997.

28. National Heart, Lung, and Blood Institute Autolo-

gous Transfusion Symposium Working Group:

Autologous transfusion: Current trends and

research issues. Transfusion 35:525, 1995.

29. Linden JV, Wagner K, Voytovich AE, et al: Transfu-

sion errors in New York State: An analysis of 10

years’ experience. Transfusion 40:1207, 2000.

30. Etchason J, Petz L, Keeler E, et al: The cost effective-

ness of preoperative autologous blood donations. N

Engl J Med 332:719, 1995.

31. Birkmeyer JD, Goodnough LT, AuBuchon JP, et al:

The cost-effectiveness of preoperative autologous

blood donation for total hip and knee replacement.

Transfusion 33:544, 1996.

32. Goodnough LT, Brecher ME, Monk TG: Acute

normovolemic hemodilution in surgery. Hemato-

logy 2:413, 1992.

33. Messmer K, Kreimeier M, Intagliett A: Present state of

intentional hemodilution. Eur Surg Res 18:254, 1986.

34. Brecher ME, Rosenfeld M: Mathematical and com-

puter modeling of acute normovolemic hemodilu-

tion. Transfusion 34:176, 1994.

35. Goodnough LT, Grishaber JE, Monk TG, et al: Acute

normovolemic hemodilution in patients under-

going radical suprapubic prostatectomy: A case

study analysis. Anesth Analg 78:932, 1994.

36. Goodnough LT, Bravo J, Hsueh Y, et al: Red blood

cell volume in autologous and homologous units:

Implications for risk/benefit assessment for autolo-

gous blood “crossover” and directed blood transfu-

sion. Transfusion 29:821, 1989.

37. Weiskopf RB: Mathematical analysis of isovolemic

hemodilution indicates that it can decrease the need

for allogeneic blood transfusion. Transfusion 35:37,

1995.

38. Petry AF, Jost T, Sievers H: Reduction of homolo-

gous blood requirements by blood pooling at the

onset of cardiopulmonary bypass. J Thorac Cardio-

vasc Surg 1097:1210, 1994.

39. Monk TG, Goodnough LT, Brecher ME, et al: A

prospective, randomized trial of three blood con-

servation strategies for radical prostatectomy. Anes-

thesiology 91:24, 1999.

40. Goodnough LT, Merkel K, Monk TG, et al: A rando-

mized trial of acute normovolemic hemodilution

compared to preoperative autologous blood donation

in total knee arthroplasty. Vox Sang 77:11, 1999.

41. Goodnough LT, Despotis GJ, Merkel K, et al: A ran-

domized trial of acute normovolemic hemodilution

compared to preoperative autologous blood donation

in total hip arthroplasty. Transfusion 40:1054, 2000.

42. Davies MJ, Cronin KD, Domaingue C: Haemodilu-

tion for major vascular surgery using 3.5% polygeline

(Haemaccel). Anaesth Intensive Care 10:265, 1982.

43. Sejourne P, Poirier A, Meakins JL, et al: Effects of

haemodilution on transfusion requirements in liver

resection. Lancet 2:1380, 1989.

44. Rosenberg B, Wulff K: Regional lung function follo-

wing hip arthroplasty and preoperative normovole-

mic hemodilution. Acta Anaesthesiol Scand 23:242,

1979.

45. Kafer ER, Isley MR, Hansen T, et al: Automated

acute normovolemic hemodilution reduces blood

transfusion requirements for spinal fusion [abs-

tract]. Anesth Analg 65(Suppl):S76, 1986.

46. RoseD,Cou

stoftidesT:Intraoperativenormovolemic

hemodilution. J Surg Res 31:375, 1981.

47. Ness PM, Bourke DL, Walsh PC: A randomized trial

of perioperative hemodilution versus transfusion of

preoperatively deposited autologous blood in elec-

tive surgery. Transfusion 31:226, 1991.

48. Monk TG, Goodnough LT, Birkmeyer JD, et al:

Acute normovolemic hemodilution is a cost-effec-

tive alternative to preoperative autologous blood

donation by patients undergoing radical retropubic

prostatectomy. Transfusion 35:559, 1995.

49. Monk TG, Goodnough LT, Brecher ME, et al: Acute

normovolemic hemodilution can replace preopera-

tive autologous blood donation as a standard of care

for autologous blood procurement in radical pros-

tatectomy. Anesth Analg 85:953, 1997.

50. Goodnough LT, Monk TG, Brecher ME: Acute

normovolemic hemodilution should replace preo-

perative autologous blood donation before elective

surgery. Transfusion 38:473, 1998.

51. Monk TG: Is Acute Normovolemic Hemodilution

Cost Effective? In: Fleisher LA (ed): Evidence-Based

Practice of Anesthesiology. Philadelphia, Saunders,

2004, pp 205–209.

52. Briggs AH, O’Brien BJ: The death of cost-minimi-

zation analysis? Health Econ 10:179, 2001.

53. Williamson KR, Taswell HF: Intraoperative blood

salvage: A review. Transfusion 31:662, 1991.

54. Domen RE: Adverse reactions associated with auto-

logous blood transfusion: Evaluation and incidence at

a large academic hospital. Transfusion 38:296, 1998.

55. Gregoretti S: Suction-induced hemolysis at various

vacuum pressures: Implications for intraoperative

blood salvage. Transfusion 36:57, 1996.

56. Bell K, Stott K, Sinclair CJ, et al: A controlled trial

of intraoperative autologous transfusion in cardiot-

horacic surgery measuring effect on transfusion

requirements and clinical outcome. Transfus Med

2:295, 1992.

57. Solomon MD, Rutledge ML, Kane LE, et al: Cost

comparison of intraoperative autologous versus

homologous transfusion. Transfusion 28:379, 1988.

58. Claggett GP, Valentine RJ, Jackson MR, et al: A

randomized trial of intraoperative transfusion

during aortic surgery. J Vasc Surg 29:22, 1999.

59. Autologous Transfusion Committee: Guidelines for

Blood Recovery and Reinfusion in Surgery and

Trauma. Bethesda, MD, American Association of

Blood Banks, 1997.

60. de Haan J, Boonstra P, Monnink S, et al: Retransfusion

of suctioned blood during cardiopulmonary bypass

impairs hemostasis. Ann Thorac Surg 59:901, 1995.

61. Ward HB, Smith RA, Candis KP, et al: A prospective,

randomized trial of autotransfusion after routine

cardiac surgery. Ann Thorac Surg 56:137, 1993.

62. Roberts SP, Early GL, Brown B, et al: Autotransfu-

sion of unwashed mediastinal shed blood fails to

decrease banked blood requirements in patients

undergoing aorta coronary bypass surgery. Am J

Surg 162:477, 1991.

Bibliografía

1558

Control de la anestesia

III